Vasomax Review Paper Published in World Journal of Urology.Business Editors & Health/Medical Writers THE WOODLANDS, Texas--(BW HealthWire)--March 7, 2001 Zonagen, Inc. (Nasdaq:ZONA)(PCX (1) A bitmapped graphics file format that handles monochrome, 2-bit, 4-bit, 8-bit and 24-bit color and uses RLE to achieve compression ratios of approximately 1.1:1 to 1.5:1. Images with large blocks of solid colors compress best under the RLE method. See PC Paintbrush. :ZNG ZNG Zbor Nacionalne Garde (Croatian National Guard) ) announced today that a review paper on its product, Vasomax(R), has been published in a leading urology journal. The paper which appeared in the February issue of the World Journal of Urology (vol.19;no.1:51-56), and co-authored by three leading clinical investigators of new treatments for erectile dysfunction Erectile Dysfunction Definition Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse. , provides an overview of laboratory and clinical data concerning phentolamine mesylate phentolamine mesylate, (fentol´  mēn´ mes´ilāt´),n brand name: Regitine; drug class: , a non-specific adrenergic receptor antagonist, and the active ingredient in Vasomax(R). Apart from a basic overview of the role adrenergic receptor blockade plays in the facilitation of penile penile /pe·nile/ (pe´nil) of or pertaining to the penis. pe·nile adj. Of or relating to the penis. penile of or pertaining to the penis. erection, the authors summarize the efficacy and safety data gathered by the Company on Vasomax(R) in large scale, placebo-controlled clinical trials. Dr. Irwin Goldstein (Boston, MA) concluded: "The results of clinical trials with Vasomax(R) support the concept of adrenergic blockade as a clinically relevant mechanism in the treatment of male erectile dysfunction." Vasomax(R) is Zonagen's oral therapy for the treatment of erectile dysfunction. The product in on partial clinical hold in the United States pending the outcome of a mechanistic rodent study started in the fourth quarter of 2000. The registration process is currently ongong in the United Kingdom. Any statements that are not historical facts contained in this release are forward looking statements that involve risks and uncertainties, including but not limited to those relating to the uncertainties related to the Company's early stage of development, clinical trial results and FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval in the U.S. and approval of regulatory authorities in other jurisdictions, substantial dependence on one product, history of operating losses, future capital needs and uncertainty of additional funding, uncertainty of protection for patents and proprietary technology, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. , governmental regulation, limited sales and marketing experience and dependence on collaborators, manufacturing uncertainties and reliance on third parties, competition and technology change, product liability and availability of insurance, and other risks identified in the Company's Annual Report on Form 10-K for the year ended December 31, 1999, as filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion